Product Profile of Ceftazidime 250/500/1000 mg Injection
Ceftazidime 250/500/1000 mg Injection has expanded coverage of pathogens. Ceftazidime 250/500/1000 mg has high stability against beta-lactamases. Ceftazidime 250/500/1000 mg Injection ensures deeper respiratory penetration in bronchial, sinus and pleural tissues.
